Laboratory equipment specialist KNAUER wanted to help save the world and now received German Innovation Award
The German Innovation Award 2022 was presented in Munich on April 29. A large number of research-intensive companies had applied for the prestigious award, which is presented annually by WirtschaftsWoche.
Innovation winner KNAUER in the category medium-sized companies: Managing Director Alexandra Knauer with laudator Beat Balzli and her team Anja Roden, Daniela Fehr, Carsten Losch at the award ceremony (from left to right).
Marc-Steffen Unger
The jury, it was reported, had a hard time choosing, as only three companies from Germany were to receive the coveted prize for their forward-looking product innovations. For each of the three categories, startups, SMEs and large companies, three finalists traveled to Munich for the festive, grand awards ceremony. The nine teams were very excited and had butterflies in their stomachs, because it had been kept top secret until the last moment which three companies would be awarded.
KNAUER made the running in the medium-sized company category: Team leader Daniela Fehr, department head Anja Roden and managing directors Alexandra Knauer and Carsten Losch were beaming when they were allowed on stage. Chief editor Beat Balzli of WirtschaftsWoche was impressed by the short time in which KNAUER had designed and manufactured novel large-scale plants for the encapsulation of mRNA at its own risk. Equipment for the production of millions of mRNA vaccine doses had never been manufactured by any company before.
Mr. Balzli asked the team on stage why this project was made at KNAUER and given top priority. Company owner Alexandra Knauer replied, "We all agreed. We wanted to do our part to save the world from COVID-19."
More than two billion vaccine doses have now been produced worldwide using KNAUER equipment. Managing Director Carsten Losch reported how this very special development project began and that the expertise of the employees and the high added value at KNAUER were factors in its success. Anja Roden informed that KNAUER's decades of experience in high-pressure pump technology and mixing technology were important prerequisites for the quick implementation. Recently, the portfolio was expanded to include screening and the production of smaller quantities of lipid nanoparticles for personalized therapies.
The Berlin-based medium-sized company KNAUER is delighted to receive this special award in the anniversary year "60 years of KNAUER". Laudator and WirtschaftsWoche editor-in-chief Beat Balzli described medium-sized businesses as the secret backbone of the German economy. At the end of a company visit to KNAUER, Dr. Angela Merkel called the company a "pearl of the SME sector" in September 2021.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Combining therapies appears safe, may benefit patients with advanced liver cancer, UF scientists say
The future of personalized cancer treatment: An entirely new direction for RNAi delivery
Proven for the First Time: The Microbiome of Fruit and Vegetables Positively Influences Diversity in the Gut - Bacterial diversity in the gut plays an important role in human health
Protein interactions: who is partying with whom and who is ruining the party? - New method for investigating protein interaction networks - also of interest for pharmaceutical research
Researchers identify phosphorylation process vital to cancer growth
Ebola virus disarmed by excising a single gene
A novel human stem cell-based model of ALS opens doors for rapid drug screening
